Burroughs Amy L.
- SEC CIK
- 0001872564
In the past year, 4 open-market sale filings worth $6.52M and no purchases.
Current role at each company
- TNYA Tenaya Therapeutics, Inc.Directoras of May 29, 2026
- TERN Terns Pharmaceuticals, Inc.Chief Executive Officeras of May 5, 2026
- DMAC DiaMedica Therapeutics Inc.Directoras of Jan 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.52M
- 4 filings
- Net
- −$6.52M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Burroughs Amy L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TERN Terns Pharmaceuticals, Inc.
Chief Executive Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Burroughs Amy L.Chief Executive Officer | SSale | −14.6K | $46.71 | −$681.2K | −4.8%289.0K after | 2 lots10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Burroughs Amy L.Chief Executive Officer | SSale | −14.6K | $39.20 | −$571.6K | −4.8%289.0K after | 3 lots10b5-1 |
| Jan 16, 2026 (view filing) | Jan 15 | 1 day | Burroughs Amy L.Chief Executive Officer | SSale | −68.7K | $37.08 | −$2.55M | −19.2%289.0K after | 2 lots10b5-1 |
| Jan 6, 2026 (view filing) | Jan 5 | 1 day | Burroughs Amy L.Chief Executive Officer | SSale | −71.3K | $38.10 | −$2.72M | −33.9%139.0K after | |
| Jun 25, 2025 (view filing) | Jun 25 | Same day | Burroughs Amy L.Chief Executive Officer | PPurchase | +23.3K | $3.87 | +$90.2K | +98.1%47.1K after | |
| Feb 3, 2025 (view filing) | Nov 30, 2024 | 65 daysLate | Burroughs Amy L.Chief Executive Officer | PPurchase | +510 | $5.11 | +$2.61K | +2.7%19.6K after | |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Burroughs Amy L.Chief Executive Officer | PPurchase | +15.4K | $7.15 | +$110.5K | +423.4%19.1K after |
DMAC DiaMedica Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Burroughs Amy L.Director | PPurchaseVoting Common Shares, no par value per share | +45.0K | $3.15 | +$141.6K | New position45.0K after |